Target intelligence / Profile preview

Aquaporin-6 (AQP6)

Target
AQP6
Molecular classification
Transporter, Ion channel, Major intrinsic protein family (MIP family), Aquaporin family (water and anion channel)
01

Overview

Aquaporin-6 (AQP6) is a member of the aquaporin membrane protein family and is encoded by the AQP6 gene in humans. It is predominantly expressed in intracellular vesicles within renal epithelial cells and less commonly found at the plasma membrane. While most aquaporins function as selective water channels, AQP6 is notable for its ability to transport anions (such as nitrate and chloride) in response to acidic pH and to partially function as a water channel. Its physiological significance includes participation in renal acid–base homeostasis and possibly in processes like glomerular filtration and endocytosis in the kidney. It is activated by mercurial compounds and exhibits unique amino acid substitutions affecting transport selectivity, making it biochemically distinct within the major intrinsic protein (MIP) family. There are currently no established disease indications or clinical therapeutics targeting AQP6, but it is of interest for antibody-based detection and research on renal epithelial cell function.

Other names
Aquaporin-2-likeKidney-specific aquaporinhKIDAQP2LKIDAquaporin-6
02

Mechanism of action

Mercury ions (Hg²⁺) activate AQP6, increasing its anion channel permeability; amino acid mutations (e.g., N60G) can switch its specificity from anion to water channel

03

Biological functions

Water transportAnion transport (nitrate, chloride, etc.)Acid–base regulationGlomerular filtrationTubular endocytosis
04

Disease associations

Other (primarily kidney/renal function; no direct links to specific diseases like cancer or cardiovascular disease currently established in human clinical context)
05

Safety considerations

No notable safety concerns or therapeutic challenges described; as a membrane protein, potential challenges may include difficulty with heterologous expression and trafficking in experimental systems
06

Interacting drugs

Hg²⁺ (mercury ion)
07

Biomarkers

None clinically established; experimental use of anti-AQP6 antibody for tissue studies

Beyond the preview

Go deeper on Aquaporin-6 (AQP6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aquaporin-6 (AQP6).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call